Diabetes

The AJMC^® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Rural health sign | Image credit: BJP7images - stock.adobe.com

FQHCs Show Low Engagement in Hypertension, Diabetes Trials

By Pearl Steinzor

April 15th 2025

A new review finds federally qualified health centers (FQHCs) are underutilized in hypertension and type 2 diabetes clinical research, despite their potential to improve trial diversity.

AI representation of housing stability | Image credit: GoldPumaze - stock.adobe.com

Housing Instability Linked to Worse Type 2 Diabetes Outcomes

By Pearl Steinzor

April 14th 2025

Diabetes concept | Image credit: Sherry Young - stock.adobe.com

GLP-1 RAs, SGLT2 Inhibitors Associated With Reduced MACE, HHF in Patients With Diabetes

By Pearl Steinzor

April 9th 2025

AJMC

The Role of Advanced Technologies in Improving Diabetes Outcomes

By David G. Marrero, PhD
Christopher G. Parkin, MS

April 7th 2025

Diabetes - Vitalii Vodolazskyi - stock.adobe.com.jpg

More Than 250 Million Individuals Unaware They Have Diabetes

By Pearl Steinzor

April 7th 2025

More News

September 30th 2017

Product Theater: Experts Present Evidence and Advice on Canagliflozin

Three physicians presented results of CANVAS and CANVAS-R, as well as other studies, and invited questions about the use of canagliflozin in primary care.

Podcast: This Week in Managed Care - Latest ACA Repeal Fails, and Other Health News

September 30th 2017

Podcast: This Week in Managed Care - Latest ACA Repeal Fails, and Other Health News

Every week, The American Journal of Managed CareÂ® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This Week in Managed Care: September 29, 2017

September 29th 2017

This Week in Managed Care: September 29, 2017

This week, the top managed care stories included the end of the latest attempt to repeal the Affordable Care Act; a call to better include the patient's voice in cancer quality metrics; and an argument for caution regarding the newly approved CAR T-cell therapy, Kymriah.

September 29th 2017

Fast-Acting Insulin Aspart for Mealtime Gains FDA Approval

Christina Mattina

Novo Nordisk announced that the FDA has approved its insulin aspart injection Fiasp, which can rapidly improve glycemic control at mealtimes for patients with type 1 and type 2 diabetes.

September 28th 2017

FDA Approves Abbott Continuous Glucose Monitor That Doesn't Need Routine Finger Sticks

A continuous glucose monitor (CGM) device made in the United States is finally approved for use here after patients in 40 other countries already have access.

September 28th 2017

HHS Issues Call for Tech Solutions to Childhood Obesity in Low-Income Communities

Christina Mattina

HHS has challenged mobile app developers and other technology innovators to create an intervention to promote nutrition, health, and fitness among low-income children and families.

September 27th 2017

FDA Announces Pilot Participants in Technology PreCert Program

Christina Mattina

The FDA has announced the 9 companies that will participate in a pilot precertification program to speed the approval of digital health software.

September 26th 2017

Sanofi, Innovation Health Launch Pilot Program in Diabetes Care Delivery

The pilot program is the latest venture among stakeholders in diabetes care to look for ways to deploy patient data to improve outcomes and hold down costs.

September 25th 2017

Dexcom Launches API to Promote Diabetes App Innovation

The move to give entrepreneurs access to patient-approved continuous glucose monitoring data fits with the company's prediction that insulin pumps will become a thing of the past, and most of the heavy lifting of delivery will be done by a smartphone.

Dr Paul Chew Discusses the Importance of Chronic Disease Prevention

September 25th 2017

Dr Paul Chew Discusses the Importance of Chronic Disease Prevention

With 35% of Americans having prediabetes, prevention is clearly a priority, but many strategies have not bee translated into clinical practice because there is no system for reimbursement yet, explained Paul Chew, MD, chief medical officer of Omada Health

September 24th 2017

Outcomes-Based Pricing for PCSK9 Inhibitors

Inmaculada Hernandez, PharmD, PhD

Outcomes-based pricing arrangements for pharmaceuticals are increasingly popular. In this piece, we discuss the impact of the outcomes-based pricing arrangements proposed by Amgen on the pricing of PCSK9 inhibitor therapy, and we provide recommendations for payers on the design of outcomes-based contracts.

September 23rd 2017

UnitedHealthcare's Medtronic Deal Sparks Furor, but a Year Later, Innovation Continues

UnitedHealthcare has not released numbers on how many patients are affected by its exclusivity deal with Medtronic. While the initial press stories criticizing the transaction have died down, a JDRF initiative calls on insurers to preserve patient choice.

September 23rd 2017

Latest Results on Intarcia's Mini-Pump Show "Clear Value to Payers," Says Study Author

Studies presented at the American Diabetes Association Scientific Sessions showed that patients being treated with the ITCA 650 were less likely to need to take additional therapy to control their diabetes.

September 22nd 2017

J&J's OneTouch Reveal: Connecting Diabetes Patients With Physicians, Managed Care

The latest version of the free app offers patients a simple color-coding system to track their blood sugar status, as well as an easy way to share data with their physicians and perhaps their health plan.

September 22nd 2017

Secure Patient—Provider Messaging Associated With Positive T2D Outcomes

Christina Mattina

Patients using secure online messaging to communicate with their healthcare providers about their type 2 diabetes (T2D) demonstrated improved clinical outcomes, according to a new study.

September 22nd 2017

After 20 Years of Watching Diabetes Tech, Kliff Eyes Smart Insulin Pens, CGM for Patients With Type 2 Diabetes

An experienced market watcher who has diabetes predicts the key to success will come down to one factor: ease of use.

September 21st 2017

Omada's Paul Chew, MD: From Treating Chronic Disease to Prevention

The chief medical officer of Omada Health discusses a transition from one of the world's largest pharmaceutical companies to a digital health provider, and from treating chronic disease to preventing it.

September 21st 2017

Study Finds Areas of Bone Damage in Seniors With Type 2 Diabetes

Authors of the study say the technology exists to screen seniors with type 2 diabetes and identify those at risk of a fracture.

September 20th 2017

AADE to Work on Diabetes Prevention With Truck Drivers, Other At-Risk Groups

Truck drivers were identified in a Gallup survey as the profession most at risk for type 2 diabetes.

September 19th 2017

Fine-tuning Enzyme Could Help Manage Diabetes, Obesity, Cancer

Experiments with baker's yeast showed why a fat-regulating enzyme is needed in the body.

September 18th 2017

Consumption of Salt Associated With Increased Risk of Type 2 Diabetes, Researchers Say

Laura Joszt, MA

Salt intake may be associated with an increased risk of developing diabetes. Research presented at the annual meeting of the European Association for the Study of Diabetes and published in Diabetologia found sodium intake increased the risk of developing both type 2 diabetes and latent autoimmune diabetes in adults.

September 18th 2017

Pager-Horizon BCBSNJ Agreement Looks to Shake Up the User Experience

While many payers, and the Blues in particular, have invested in digital health startups, a new agreement will pair Horizon with a company whose philosophy rejects the operating mentality of most insurers.

Dr Michael Thase: Screening for Depression Has to Be Coupled With Intervention

September 17th 2017

Dr Michael Thase: Screening for Depression Has to Be Coupled With Intervention

Screening for depression in the primary care setting can take as little as 30 seconds, but screening is only effective if it actually leads to intervention, explained Michael E. Thase, MD, professor of psychiatry and director of the Mood and Anxiety Program at the University of Pennsylvania.

September 15th 2017

Sotagliflozin Reduces A1C With Less Insulin in Type 1 Diabetes, but DKA Rates Increase

Researchers noted that the oral therapy functions independently of insulin to carry excess blood glucose out of the system.

September 14th 2017

Sanofi: Patient-Driven Insulin Titration Better for A1C

The results support policy positions that diabetes self-management education and support should occur at transitions in care.

September 13th 2017

A Heavier Wife Can Lead to a Husband's Diabetes, Study Finds

The results were profound enough that researchers say it might be wise to screen patients for diabetes if their spouse is obese.

September 12th 2017

Medtronic Announces Recall of Diabetes Infusion Sets

The problem caused an overdelivery of insulin in some cases. A design update in April 2017 corrected the problem but some patients still have lots of defective infusion sets.

September 12th 2017

Bringing Drugs to Market Costs Less Than Previously Thought, Study Finds

Christina Mattina

How much does it cost for a drug maker to develop a new drug? Prior estimates have put this figure as high as $2.7 billion, but a new study indicates that the median cost of development for 10 cancer drugs was actually $648 million-a substantial discrepancy.

September 12th 2017

CMS Must Add Virtual Providers, Revamp Payment for Diabetes Prevention Program

A group that represents both community-based and virtual providers finds many issues with CMS' proposal for Medicare's Diabetes Prevention Program.

September 11th 2017

Quest Moves to More Accurate, Nonfasting Cholesterol Test Method

As physicians treat patients with elevated low-density lipoprotein (LDL) cholesterol more aggressively with PCSK9 inhibitors and high-efficacy statins, a test that is more accurate at lower levels is essential.

...

32 33 34 35 36 37 38 39 40

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions